Pharma-Bio Serv Inc (PBSV)

Pharma-Bio Serv Inc is a common stock listing on OTC Markets for a healthcare-sector company focused on regulatory affairs, compliance, and technology transfer consulting. Based in Dorado, Puerto Rico, the company provides technical support across areas such as quality assurance, validation, engineering, project management, process support, and related compliance functions. Its services are directed to clients in the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, and food industries, as well as allied product companies. Founded in 1993, Pharma-Bio Serv also serves customers in Puerto Rico, the United States, Europe, Brazil, and other international markets.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-PBSV
$0.60
36.2% Upside
Undervalued
$1.55
252.3% Upside
Bargain
Good
16.0%
February 1, 2027
42.8x
1.0x
1.1x
10.077 M
2.187 M
0.0%
36.7%
9.5
682.9%
-167.5%
Valuation • Fair Value

Pharma-Bio Serv Inc (OTC-PBSV) Fair Value by Valuation Model

Review the available estimates for Pharma-Bio Serv Inc (OTC-PBSV), including Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.60

Estimated upside of 36.2% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Ben Graham Formula Value

$0.12

Classic Ben Graham valuation formula reference.

DDM Fair Value

$0.74

Dividend discount model valuation reference.

EPV Fair Value

$0.64

Earnings power value estimate.

Comps Fair Value

$0.56

Comparable-company valuation reference.

Analyst Price Target

$1.55

Analysts imply upside of 252.3%.

How to read these valuation models

Use the 7 available valuation references for Pharma-Bio Serv Inc (OTC-PBSV) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Pharma-Bio Serv Inc (OTC-PBSV)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

9.484 M

Current operating scale indicator.

Revenue Forecast

11 M

Forward revenue estimate.

EBITDA

-97.005 K

Current operating profitability reference.

EBITDA Forecast

4.787 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Pharma-Bio Serv Inc (OTC-PBSV) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Pharma-Bio Serv Inc (OTC-PBSV)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.13

Intermediate zone that deserves monitoring.

Altman Z-Score

9.5

Relatively strong balance-sheet zone.

FCF / Net Income

-167.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Pharma-Bio Serv Inc (OTC-PBSV). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Pharma-Bio Serv Inc (OTC-PBSV)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

February 1, 2027

Days to Earnings

132

Dividend Yield

16.0%

Current income yield reference.

Payout Ratio

682.9%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Pharma-Bio Serv Inc (OTC-PBSV), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Pharma-Bio Serv Inc (OTC-PBSV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Pharma-Bio Serv Inc (OTC-PBSV) Stock FAQ

Data-supported answers about Pharma-Bio Serv Inc (OTC-PBSV), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.60
Estimated upside 36.2%
Valuation Rating
Undervalued
Estimated upside of 36.2%
Analyst Target
$1.55
Implied upside 252.3%
Financial Health
Good
Current financial-health read

The current fair value estimate for Pharma-Bio Serv Inc (OTC-PBSV) is $0.60. This implies an estimated upside of 36.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 36.2% versus the current market price.

The available analyst price target for Pharma-Bio Serv Inc (OTC-PBSV) is $1.55. The analyst target implies estimated upside of 252.3%.

The current financial health read for Pharma-Bio Serv Inc (OTC-PBSV) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Pharma-Bio Serv Inc (OTC-PBSV) is February 1, 2027.

Based on the current data, dividend yield is 16.0%.

The current P/E ratio listed for Pharma-Bio Serv Inc (OTC-PBSV) is 42.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Pharma-Bio Serv Inc is 10.077 M.

The current enterprise value listed for Pharma-Bio Serv Inc is 2.187 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Pharma-Bio Serv Inc is OTC-PBSV, and the stock is listed on OTC Markets.

Pharma-Bio Serv Inc (OTC-PBSV) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Pharma-Bio Serv Inc is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Pharma-Bio Serv Inc is 36.7%. Free float helps investors understand how much of the share base is available for public trading.